News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Dyadic International, Inc. Reports 2006 Second Quarter Financial Results
August 11, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
JUPITER, Fla.--(BUSINESS WIRE)--Aug. 11, 2006--Dyadic International, Inc. (AMEX:DIL), a biotechnology company, today announced financial results for the second quarter and six-months ended June 30, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Insights
JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
January 15, 2026
·
2 min read
·
Jennifer Smith-Parker
Cancer
JPM26: AbbVie Seeks Respect for Oncology Pipeline Following RemeGen Buy
January 14, 2026
·
2 min read
·
Heather McKenzie
HIV
JPM26: Gilead Captures Sunny JPM Mood With Yeztugo Numbers, HIV Vibes
January 14, 2026
·
3 min read
·
Dan Samorodnitsky
Business
JPM26: Lilly Plots Path to Dominance as Obesity Market Enters a New Era
January 14, 2026
·
2 min read
·
Nick Paul Taylor
